TOMAHAWK: Difference between revisions

TOMAHAWK (view source)

751 bytes added , 16 February 2022

73

edits

@@ Line 135: / Line 135: @@
 ; Acute renal failure requiring renal replacement therapy:
 : 18.9% vs. 15.8% (RR 1.14; 0.78-1.68)
 ===Subgroup Analysis===
 <!-- Was there a subgroup analysis? If so, include a summary of it here. -->
-Age (greater or less than 65 years old)
+The subgroup analysis (values list below) did not show any significant differences
-Diabetes
-Shockable vs Non-schockable rhythm
+;Age greater that 65 years old
-Confirmed MI as trigger
+: 63% vs 54% (HR 1.29, CI 0.97 - 1.73)
-Sex
-Targeted temperature management
+; Age less than 65 years old
-Time from arrest to ROSC
+: 40% vs 31% (HR 1.37, CI 0.84 - 2.23)
+;History of diabetes
+: 69% vs 62% (HR 1.19, CI 0.78 - 1.18
+:No diabetes
+: 47% vs 39% (HR 1.32, CI 0.95 - 1.83)
+:Non-shockable rhythm
+: 73% vs 68% (HR 1.24, CI 0.88 - 1.75)
+;Shockable rhythm
+: 39% vs 30% (HR 1.44, CI 0.95 - 2.19
+;OHCA triggered MI
+: 50 % vs 40% (HR 1.34, CI 0.95 - 1.89)
+;Non-OHCA triggered MI
+: 38% vs 42% (HR 0.97, CI 0.50 - 1.90)
+;Male sex
+: 51% vs 47% (HR 1.14, CI 0.84 - 1.53)
+;Female sex
+: 62% vs 46% (HR 1.64, CI 1.06 - 2.54)
+;TTM
+: 56% vs 47% (HR 1.26, CI 0.96 - 1.67)
+;No TTM
+:  47% vs 45% (HR 1.34, CI 0.77 - 2.33)
+;Time greater than 15 min to ROSC
+: 58% vs 57% (HR 1.02, CI 0.76 - 1.36)
+;Time less than 15 min to ROSC
+: 34% vs 30% (HR 1.52, CI 0.78 - 2.93)
 ===Adverse Events===